Laboratorio Reig Jofre, S.A.

MCE RJF.MC

Laboratorio Reig Jofre, S.A. Total Assets for the year ending December 31, 2023: USD 364.84 M

Laboratorio Reig Jofre, S.A. Total Assets is USD 364.84 M for the year ending December 31, 2023, a 6.17% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
  • Laboratorio Reig Jofre, S.A. Total Assets for the year ending December 31, 2022 was USD 343.66 M, a -7.10% change year over year.
  • Laboratorio Reig Jofre, S.A. Total Assets for the year ending December 31, 2021 was USD 369.94 M, a -4.51% change year over year.
  • Laboratorio Reig Jofre, S.A. Total Assets for the year ending December 31, 2020 was USD 387.42 M, a 10.08% change year over year.
  • Laboratorio Reig Jofre, S.A. Total Assets for the year ending December 31, 2019 was USD 351.95 M, a 39.99% change year over year.
Key data
Date Total Assets Current Liabilities Total Non-Current Liabilities Shareholders' Equity
Market news
Loading...
MCE: RJF.MC

Laboratorio Reig Jofre, S.A.

CEO Mr. Ignasi Biosca Reig
IPO Date Nov. 29, 2002
Location Spain
Headquarters Gran Capita, 10
Employees 1,331
Sector Health Care
Industries
Description

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand. The company also provides CDMO and CMO services. It sells its products directly in 7 countries and through business partners in approximately 70 countries. The company was founded in 1929 and is based in Sant Joan Despí, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.

Similar companies

PHM.MC

Pharma Mar, S.A.

USD 77.86

1.89%

ROVI.MC

Laboratorios Farmaceuticos Rovi, S.A.

USD 59.78

-0.59%

FAE.MC

Faes Farma, S.A.

USD 3.46

-1.45%

ALM.MC

Almirall, S.A.

USD 8.60

3.71%

ORY.MC

Oryzon Genomics S.A.

USD 1.51

-0.07%

StockViz Staff

January 15, 2025

Any question? Send us an email